• L&C Bio CEO Lee Whan-chul cut holdings of specific securities to 5,928,022 shares, or 21.64%, as of Sept. 30.
• The change reflected an off-market sale of 428,909 share subscription rights on Sept. 22.
• Common share stake stayed at 5,499,114 shares, or 20.39%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. L&C Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000842), on September 30, 2026, and is solely responsible for the information contained therein.